CurifyLabs has secured $14 million in Series A funding just 14 months after its last round. Sandwater and HealthCap co-led the round, with Tesi and Lifeline Ventures also participating.
This Finnish healthtech company automates pharmacy compounding, a typically manual and error-prone process. Compounding creates custom-dosed medicines for children, cancer patients, and others who cannot use standard drugs.
With this round, CurifyLabs’ total funding now exceeds $19 million.
In May 2025, CurifyLabs raised €6.7 million to support its pharmacy compounding automation. 14 months later, it secured another $14 million, with Sandwater and HealthCap co-leading the round, with Tesi and Lifeline Ventures also participating.
This quick pace of fundraising is unusual for a Series A healthtech company, especially one that already has grants and loans. Tech Funding News has not yet found out why the company needed capital so quickly.
